News Room

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer.  The storied achievements of our life sciences sector – our biopharmaceutical, biotech, diagnostic

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer Among our many learnings from the COVID-19 pandemic is that a robust and

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer and Anthony S. Cicatiello, President of the R&D Council of New Jersey …

About 1 in 11 Americans, and 350 million people worldwide, suffer from a rare disease, defined as a disease affecting less than 200,000 people in the United States. …

The Star-Ledger’s recent editorial, “Drug prices are obscene, and (Gov. Phil) Murphy is blocking the smart solution,” left out key facts regarding the role of drug manufacturers in determining what patients pay for name-brand medicines. …

Trenton, July 29, 2022 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning